Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...

In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.

By targeting original design flaws and using superior components, specialized repair services can create a stronger, more dependable piece of equipment. In this article, Global Electronic Services ...

More than 90% of drugs that appear safe and effective in animal studies ultimately fail once they reach human trials, and the consequences are staggering: billions of dollars wasted, delays in new ...

Taking effect on Jan. 1, 2026, SB 243 is directed at regulating AI-powered companion chatbots (with limited exceptions) that engage users across multiple interactions, with a multi-pronged approach.

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...